Topic: Official INNBC InnovativeBioresearchCoin Thread - trading, updates, discussion - page 2. (Read 570 times)
May 05, 2020, 04:26:19 PM
inbbc supply is very interesting but unfortunately I have not seen a good volume of this coin, oh yes is it still possible to swap inbccl to inbcc, I have several inbbcl but I forgot to swap in April is there any additional opportunity? especially inbccl tokens are still traded in several dex markets.
May 05, 2020, 03:31:06 PM
http://spiderman22.altervista.org/INNBC.png
Introduction
Innovative Bioresearch Ltd is a privately held biotech company founded by Italian research scientist Jonathan Fior with the goal of bringing innovation to the field, with a focus on HIV, cancer and regeneration research. They launched INNBC and INNBCL tokens to support their AIDS cure research, and also to develop an application that provides a decentralized database for clinical data generated by future human trials, to overcome the limitations of the current centralized databases; the application will also work as a social platform for the HIV seropositive community and to access all the company’s future services.
The number of people living with HIV is 39.7m as of 2018, but nearly 40% did not receive proper treatment. The mission is to develop a low-cost cell-based therapy solution for HIV to allow access to the treatment for those individuals who are normally left untreated due to social or economic limitations. The treatment developed by Innovative Bioresearch is estimated to be a lot cheaper than antiretroviral therapy ART and any gene therapy offered by other competitors. The treatment is based on the groundbreaking research paper of Jonathan Fior (Fior J. SupT1 Cell Infusion as a Possible Cell-Based Therapy for HIV: Results from a Pilot Study in Hu-PBMC BRGS Mice. Vaccines. 2016;4:13 https://www.ncbi.nlm.nih.gov/pubmed/27128948/) that was reported by more than 230 publications worldwide such as Yahoo! Finance, Reuters, Bloomberg, MarketWatch, Boston Globe, Seeking Alpha, Wichita Business Journal, Milwaukee Journal Sentinel, News9.com, Wall Street Online Germany, and Medical News.
Decentralized clinical database
Pubmed, the main centralized clinical database, where the research is published by multiple researchers, has quite a primitive design and searching and processing data can be quite tedious for any researcher; going through all the data from previous trials, read all the papers, and manually select the useful data to create a protocol for their own trial can be quite a tedious and time-consuming process. Even the clinicians to have to go through all the papers and make a best guess on what treatment protocol should be used, as patients will have different individual characteristics, they may require personalized treatment protocols. Above all that, there is always an issue of human error.
A possible solution is the creation of a decentralized database for clinical data using blockchain technology as proposed with the creation of the “You’re not alone” application. The app would feature visual representation summarizing and processing on the fly all the data, as well as a user-friendly interface allowing any clinician running a clinical investigation to enter the data produced by their trials. The application will allow the input of a broad range of individual patient data with elaboration. This would take away the burden of having to manually search and process all the data as in the current centralized databases. The name of the application is “You’re not alone” as the objective is to also create a community where HIV seropositive people can stay up to date, comment, share, interact with the team working on the cure, and with each other too.
Token
The main purpose of token creation is designed for patients and will be used as means of payment to access all the medical services/products, is thus backed by the value of a medical product/service. In addition, the Token will be spendable to buy goods and services from a selection of prestigious commercial partners. They already have partnerships with UK based JDM car importers to give some solid intrinsic value to the token. They also have a partnership with the French electronic giant ARCHOS, where vouchers are given at discount for purchases. There are plans to use the tokens for privileged access on the app and also to reward community moderators.
The INNBC token is the main token issued for developing their novel AIDS cure research and the INNBCL token is a sister token for further expanding the research for supporting cancer/regeneration research projects. In addition, INNBCL holders are eligible for INNBC bonuses and airdrops. INNBC is traded on Crex24, Etherflyer, Mercatox, BigOne, STEX, while INNBCL is currently traded on Crex24, Idex, and Token Store.
It is the first coin launched by a biotech company developing novel AIDS cure research with decentralization in mind. In conclusion, although a centralized app system could have been implemented, decentralization is the only way to ensure there is no manipulation of the data and all information is publicly available without any forced alterations.
INNBC on cmc https://coinmarketcap.com/currencies/innovative-bioresearch-coin/
INNBCL on cmc https://coinmarketcap.com/currencies/innovative-bioresearch-classic/
Conclusion
This is a very unique approach and can be applied to the novel Coronavirus kind of diseases too where time is of the utmost importance when researching new cures and performing trials.
Introduction
Innovative Bioresearch Ltd is a privately held biotech company founded by Italian research scientist Jonathan Fior with the goal of bringing innovation to the field, with a focus on HIV, cancer and regeneration research. They launched INNBC and INNBCL tokens to support their AIDS cure research, and also to develop an application that provides a decentralized database for clinical data generated by future human trials, to overcome the limitations of the current centralized databases; the application will also work as a social platform for the HIV seropositive community and to access all the company’s future services.
The number of people living with HIV is 39.7m as of 2018, but nearly 40% did not receive proper treatment. The mission is to develop a low-cost cell-based therapy solution for HIV to allow access to the treatment for those individuals who are normally left untreated due to social or economic limitations. The treatment developed by Innovative Bioresearch is estimated to be a lot cheaper than antiretroviral therapy ART and any gene therapy offered by other competitors. The treatment is based on the groundbreaking research paper of Jonathan Fior (Fior J. SupT1 Cell Infusion as a Possible Cell-Based Therapy for HIV: Results from a Pilot Study in Hu-PBMC BRGS Mice. Vaccines. 2016;4:13 https://www.ncbi.nlm.nih.gov/pubmed/27128948/) that was reported by more than 230 publications worldwide such as Yahoo! Finance, Reuters, Bloomberg, MarketWatch, Boston Globe, Seeking Alpha, Wichita Business Journal, Milwaukee Journal Sentinel, News9.com, Wall Street Online Germany, and Medical News.
Decentralized clinical database
Pubmed, the main centralized clinical database, where the research is published by multiple researchers, has quite a primitive design and searching and processing data can be quite tedious for any researcher; going through all the data from previous trials, read all the papers, and manually select the useful data to create a protocol for their own trial can be quite a tedious and time-consuming process. Even the clinicians to have to go through all the papers and make a best guess on what treatment protocol should be used, as patients will have different individual characteristics, they may require personalized treatment protocols. Above all that, there is always an issue of human error.
A possible solution is the creation of a decentralized database for clinical data using blockchain technology as proposed with the creation of the “You’re not alone” application. The app would feature visual representation summarizing and processing on the fly all the data, as well as a user-friendly interface allowing any clinician running a clinical investigation to enter the data produced by their trials. The application will allow the input of a broad range of individual patient data with elaboration. This would take away the burden of having to manually search and process all the data as in the current centralized databases. The name of the application is “You’re not alone” as the objective is to also create a community where HIV seropositive people can stay up to date, comment, share, interact with the team working on the cure, and with each other too.
Token
The main purpose of token creation is designed for patients and will be used as means of payment to access all the medical services/products, is thus backed by the value of a medical product/service. In addition, the Token will be spendable to buy goods and services from a selection of prestigious commercial partners. They already have partnerships with UK based JDM car importers to give some solid intrinsic value to the token. They also have a partnership with the French electronic giant ARCHOS, where vouchers are given at discount for purchases. There are plans to use the tokens for privileged access on the app and also to reward community moderators.
The INNBC token is the main token issued for developing their novel AIDS cure research and the INNBCL token is a sister token for further expanding the research for supporting cancer/regeneration research projects. In addition, INNBCL holders are eligible for INNBC bonuses and airdrops. INNBC is traded on Crex24, Etherflyer, Mercatox, BigOne, STEX, while INNBCL is currently traded on Crex24, Idex, and Token Store.
It is the first coin launched by a biotech company developing novel AIDS cure research with decentralization in mind. In conclusion, although a centralized app system could have been implemented, decentralization is the only way to ensure there is no manipulation of the data and all information is publicly available without any forced alterations.
INNBC on cmc https://coinmarketcap.com/currencies/innovative-bioresearch-coin/
INNBCL on cmc https://coinmarketcap.com/currencies/innovative-bioresearch-classic/
Conclusion
This is a very unique approach and can be applied to the novel Coronavirus kind of diseases too where time is of the utmost importance when researching new cures and performing trials.
April 21, 2020, 08:54:26 AM
Dear INNBC community,
We decided to create a new official thread for INNBC given its constant expanding in popularity and recognition and its now very big community. The ANN thread was created long ago and served its purpose, so we now feel the need of creatiing a new thread for INNBC given its new powerful course.
Please stay tuned as I'll aupdate this thread constantly.
We decided to create a new official thread for INNBC given its constant expanding in popularity and recognition and its now very big community. The ANN thread was created long ago and served its purpose, so we now feel the need of creatiing a new thread for INNBC given its new powerful course.
Please stay tuned as I'll aupdate this thread constantly.
Jump to: